REGENXBIO (RGNX) News Today → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free rgnx Stock Alerts $21.81 -0.37 (-1.67%) (As of 10:44 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineREGENXBIO Announces Lancet Publication of Phase I/IIa Study Evaluating ABBV-RGX-314 as a One-Time Gene Therapy for Wet AMDprnewswire.com - March 28 at 7:05 AMREGENXBIO to Participate in Cantor Fitzgerald's Virtual DMD and Other Dystrophy Daysfinance.yahoo.com - March 27 at 5:33 PMREGENXBIO (NASDAQ:RGNX) Upgraded to Hold at StockNews.comamericanbankingnews.com - March 21 at 2:20 AMREGENXBIO (NASDAQ:RGNX) Raised to Hold at StockNews.commarketbeat.com - March 21 at 2:20 AMREGENXBIO Inc. (NASDAQ:RGNX) CEO Kenneth T. Mills Sells 15,000 Sharesamericanbankingnews.com - March 19 at 5:02 AMREGENXBIO Inc. (NASDAQ:RGNX) CEO Sells $327,900.00 in Stockinsidertrades.com - March 19 at 5:00 AMRegenxbio Inc (RGNX) President and CEO Kenneth Mills Sells 15,000 Sharesfinance.yahoo.com - March 18 at 9:18 PMREGENXBIO Inc. (NASDAQ:RGNX) Insider Steve Pakola Sells 12,878 Sharesinsidertrades.com - March 17 at 7:41 AMChardan Capital Comments on REGENXBIO Inc.'s FY2024 Earnings (NASDAQ:RGNX)marketbeat.com - March 14 at 6:57 AMRockville biotech raises $140M following layoffs, program cutsbizjournals.com - March 12 at 8:13 PMREGENXBIO (NASDAQ:RGNX) Upgraded at StockNews.commarketbeat.com - March 11 at 11:15 PMRegenxbio: DMD Program Lends Additional Credibility To NAV Technology Platformseekingalpha.com - March 11 at 2:02 PMRegenxbio initiated with bullish view at H.C. Wainwright, here's whyrealmoney.thestreet.com - March 11 at 2:02 PMHC Wainwright Initiates Coverage on REGENXBIO (NASDAQ:RGNX)marketbeat.com - March 11 at 10:23 AMREGENXBIO to Participate in Upcoming Investor Conferencesprnewswire.com - March 11 at 7:05 AMLeerink Partnrs Equities Analysts Boost Earnings Estimates for REGENXBIO Inc. (NASDAQ:RGNX)marketbeat.com - March 11 at 1:45 AMRBC Capital gets more bullish on Regenxbio, upgrades sharesrealmoney.thestreet.com - March 8 at 2:22 PMRBC Capital upgrades Regenxbio to Outperform, sees positive risk-rewardrealmoney.thestreet.com - March 8 at 2:22 PMRegenxbio raised to Buy at RBC on pivot to Duchennemsn.com - March 8 at 2:22 PMThis Gene Therapy Player Duchenne Data Is Impressive, Analyst Upgrades REGENXBIOmarkets.businessinsider.com - March 8 at 2:22 PMRegenxbio Inc (RGNX) Chief Medical Officer Steve Pakola Sells 12,878 Sharesfinance.yahoo.com - March 8 at 8:38 AMREGENXBIO (NASDAQ:RGNX) Raised to Outperform at Royal Bank of Canadamarketbeat.com - March 8 at 8:21 AMREGENXBIO Inc. (NASDAQ:RGNX) Expected to Earn Q1 2024 Earnings of ($1.24) Per Sharemarketbeat.com - March 8 at 6:19 AMBearish: Analysts Just Cut Their REGENXBIO Inc. (NASDAQ:RGNX) Revenue and EPS estimatesfinance.yahoo.com - March 7 at 3:33 PMREGENXBIO's (RGNX) Buy Rating Reaffirmed at Chardan Capitalmarketbeat.com - March 7 at 10:33 AMAnalysts Are Bullish on These Healthcare Stocks: RegenXBio (RGNX), Biomea Fusion (BMEA)markets.businessinsider.com - March 7 at 10:32 AMREGENXBIO (NASDAQ:RGNX) PT Raised to $55.00marketbeat.com - March 7 at 8:20 AMLeerink Partnrs Comments on REGENXBIO Inc.'s FY2028 Earnings (NASDAQ:RGNX)marketbeat.com - March 7 at 7:53 AMREGENXBIO (NASDAQ:RGNX) Raised to "Outperform" at Leerink Partnrsmarketbeat.com - March 7 at 6:35 AMREGENXBIO Announces Pricing of Upsized Public Offering of Common Stock and Pre-funded Warrantsprnewswire.com - March 6 at 11:20 PMLatest News for Regenxbio Stock (NASDAQ:RGNX)benzinga.com - March 6 at 6:35 PMLeerink gets more bullish on Regenxbio, upgrades sharesrealmoney.thestreet.com - March 6 at 6:35 PMLeerink more bullish on Regenxbio, upgrades to Outperformrealmoney.thestreet.com - March 6 at 6:35 PMRegenXBio’s RGX-202 Hold Rating: Balancing Promising DMD Trial Outcomes with Competitive Market Challengesmarkets.businessinsider.com - March 6 at 6:35 PMREGENXBIO's Muscle Wasting Disorder Drug Shows Strength, Improved Motor Function, Stock Soarsmsn.com - March 6 at 6:35 PMRegenxbio stock jumps 13% on positive data for DMD drugmsn.com - March 6 at 6:35 PMBeyond The Numbers: 4 Analysts Discuss Regenxbio Stockmarkets.businessinsider.com - March 6 at 6:35 PMREGENXBIO Announces Proposed Public Offering of Common Stockprnewswire.com - March 6 at 4:10 PMREGENXBIO (NASDAQ:RGNX) Upgraded to "Outperform" by SVB Leerinkmarketbeat.com - March 6 at 8:36 AMRobert W. Baird Raises REGENXBIO (NASDAQ:RGNX) Price Target to $39.00marketbeat.com - March 6 at 8:25 AMRedmile Group LLC Has $42.37 Million Stake in REGENXBIO Inc. (NASDAQ:RGNX)marketbeat.com - March 5 at 8:14 PMREGENXBIO (NASDAQ:RGNX) Reaches New 1-Year High at $28.80marketbeat.com - March 5 at 12:13 PMRegenxbio, Quoin Pharmaceuticals, Renalytix among healthcare moversmsn.com - March 5 at 10:52 AMREGENXBIO ANNOUNCES NEW POSITIVE INITIAL EFFICACY DATA FROM AFFINITY DUCHENNE® TRIALprnewswire.com - March 5 at 7:05 AMRGNX Apr 2024 15.000 callfinance.yahoo.com - March 4 at 8:26 AMRGNX Mar 2024 20.000 putfinance.yahoo.com - March 3 at 7:42 PMREGENXBIO (NASDAQ:RGNX) Stock Rating Lowered by StockNews.commarketbeat.com - March 1 at 11:16 PMOptimistic Outlook for RegenXBio’s Gene Therapy Pipeline and Regulatory Prospects Spurs Buy Ratingmarkets.businessinsider.com - March 1 at 9:59 AMWedbush Analysts Reduce Earnings Estimates for REGENXBIO Inc. (NASDAQ:RGNX)marketbeat.com - March 1 at 8:03 AMREGENXBIO to Host Webcast Event to Discuss New Interim Clinical Data from the Phase I/II AFFINITY DUCHENNE® Trialprnewswire.com - February 29 at 4:57 PM Get REGENXBIO News Delivered to You Automatically Sign up to receive the latest news and ratings for RGNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem. Protect your retirement savings from the inevitable devaluation of the dollar… RGNX Media Mentions By Week RGNX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RGNX News Sentiment▼0.470.60▲Average Medical News Sentiment RGNX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RGNX Articles This Week▼23▲RGNX Articles Average Week Get REGENXBIO News Delivered to You Automatically Sign up to receive the latest news and ratings for RGNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: IMTX News RLAY News TARS News KYTX News SRRK News BCRX News CRGX News PRME News HLVX News TRML News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RGNX) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryUrgent: Protect Your Investments from a Chinese InvasionBehind the MarketsSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding REGENXBIO Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.